4//SEC Filing
Yarema Kristin 4
Accession 0001567619-21-012110
CIK 0001604464other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:02 PM ET
Size
8.0 KB
Accession
0001567619-21-012110
Insider Transaction Report
Form 4
Yarema Kristin
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2021-06-11$14.50/sh+2,021$29,305→ 93,549 total - Purchase
Common Stock
2021-06-14$14.48/sh+3,500$50,680→ 97,049 total - Purchase
Common Stock
2021-06-14$14.58/sh+28,833$420,385→ 125,882 total
Footnotes (1)
- [F1]The reporting person's sale of ATRA common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 761 shares, with the reporting person's sale of 761 shares of ATRA common stock at a weighted average price of $14.55 per share on May 18, 2021. The reporting person has agreed to pay to ATRA $53.27, representing the full amount of the profit realized in connection with the short-swing transaction.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001803794
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:02 PM ET
- Size
- 8.0 KB